Published in Acta Neurol Belg on June 01, 2006
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain (2010) 4.77
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol (2010) 3.49
Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study. Lancet Neurol (2013) 3.06
Visualizing out-of-body experience in the brain. N Engl J Med (2007) 2.44
Status gelasticus after temporal lobectomy: ictal FDG-PET findings and the question of dual pathology involving hypothalamic hamartomas. Epilepsia (2005) 2.43
Optimized in vivo detection of dopamine release using 18F-fallypride PET. J Nucl Med (2012) 2.18
Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia (2014) 2.15
EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging (2010) 2.09
Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol (2007) 1.95
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake. Cell Metab (2008) 1.94
Deep brain stimulation in patients with refractory temporal lobe epilepsy. Epilepsia (2007) 1.84
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A (2007) 1.73
Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J Nucl Med (2009) 1.70
Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med (2009) 1.65
Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat. Exp Neurol (2007) 1.55
Longitudinal microPET imaging of brain glucose metabolism in rat lithium-pilocarpine model of epilepsy. Exp Neurol (2009) 1.52
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging (2009) 1.49
Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa. Biol Psychiatry (2011) 1.48
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia. Neuroimage (2013) 1.48
Long-term outcome of surgical disconnection of the epileptic zone as an alternative to resection for nonlesional mesial temporal epilepsy. J Neurol Neurosurg Psychiatry (2013) 1.43
The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol (2012) 1.42
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain (2008) 1.41
The use of SPECT and PET in routine clinical practice in epilepsy. Curr Opin Neurol (2007) 1.41
Automated quantitative gait analysis in animal models of movement disorders. BMC Neurosci (2010) 1.31
Long-term amygdalohippocampal stimulation for refractory temporal lobe epilepsy. Ann Neurol (2002) 1.27
Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug. CNS Drug Rev (2007) 1.26
Quantification of Parkinson's disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging (2006) 1.24
Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET. Neuroimage (2004) 1.21
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. Eur J Nucl Med Mol Imaging (2012) 1.21
Evaluation of three MRI-based anatomical priors for quantitative PET brain imaging. IEEE Trans Med Imaging (2011) 1.20
European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging (2012) 1.19
Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia (2013) 1.19
Electrical stimulation for the treatment of epilepsy. Neurotherapeutics (2009) 1.17
Neuronuclear assessment of patients with epilepsy. Semin Nucl Med (2008) 1.17
Dynamics of epileptic phenomena determined from statistics of ictal transitions. IEEE Trans Biomed Eng (2006) 1.16
Functional connectivity of dissociation in patients with psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry (2011) 1.15
Effects of MRI contrast agents on the stem cell phenotype. Cell Transplant (2010) 1.13
Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β'-site increases Aβ generation. EMBO Mol Med (2011) 1.11
Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain. J Nucl Med (2006) 1.10
Mutations in TNK2 in severe autosomal recessive infantile onset epilepsy. Ann Neurol (2013) 1.07
Abeta amyloid deposition in the language system and how the brain responds. Brain (2007) 1.05
Steroids in intractable childhood epilepsy: clinical experience and review of the literature. Seizure (2005) 1.05
Analysis of initial slow waves (ISWs) at the seizure onset in patients with drug resistant temporal lobe epilepsy. Epilepsia (2007) 1.04
Psychosocial stress is associated with in vivo dopamine release in human ventromedial prefrontal cortex: a positron emission tomography study using [¹⁸F]fallypride. Neuroimage (2011) 1.04
Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model. J Neurochem (2011) 1.02
Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study. Eur J Paediatr Neurol (2007) 1.02
Pattern recognition with the optic nerve visual prosthesis. Artif Organs (2003) 1.01
Autoimmune-mediated encephalitis. Neuroradiology (2011) 1.01
Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data. CNS Drug Rev (2007) 1.01
Measuring extrastriatal dopamine release during a reward learning task. Hum Brain Mapp (2011) 1.01
Ictal perfusion patterns associated with single MRI-visible focal dysplastic lesions: implications for the noninvasive delineation of the epileptogenic zone. Epilepsia (2006) 1.00
Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study. PLoS One (2013) 0.98
Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study. Am J Gastroenterol (2010) 0.96
Towards a neurocircuitry in anorexia nervosa: evidence from functional neuroimaging studies. J Psychiatr Res (2009) 0.96
Kinetic analysis of the cannabinoid-1 receptor PET tracer [(18)F]MK-9470 in human brain. Eur J Nucl Med Mol Imaging (2009) 0.96
Neurodegenerative Parkinsonism and progressive external ophthalmoplegia with a Twinkle mutation. Mov Disord (2009) 0.95
Continuous epileptiform discharges in patients treated with cefepime or meropenem. Arch Neurol (2011) 0.95
Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain. J Nucl Med (2010) 0.95
Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners. Clin Linguist Phon (2007) 0.94
Weighted conditional random fields for supervised interpatient heartbeat classification. IEEE Trans Biomed Eng (2011) 0.93
Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur J Nucl Med Mol Imaging (2012) 0.93
COMT Val158Met genotype selectively alters prefrontal [18F]fallypride displacement and subjective feelings of stress in response to a psychosocial stress challenge. PLoS One (2013) 0.93
A finite difference method with reciprocity used to incorporate anisotropy in electroencephalogram dipole source localization. Phys Med Biol (2005) 0.93
Accurate epileptogenic focus localization through time-variant functional connectivity analysis of intracranial electroencephalographic signals. Neuroimage (2011) 0.93
Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine? Eur J Nucl Med Mol Imaging (2007) 0.93
Levodopa-induced alterations in speech rate in advanced Parkinson's disease. Acta Neurol Belg (2006) 0.92
Dipole estimation errors due to differences in modeling anisotropic conductivities in realistic head models for EEG source analysis. Phys Med Biol (2008) 0.92
Altered default-mode network activation in mild cognitive impairment compared with healthy aging. Neuroradiology (2012) 0.92
Long-term deep brain stimulation for refractory temporal lobe epilepsy. Epilepsia (2005) 0.91
Chronic levetiracetam treatment early in life decreases epileptiform events in young GAERS, but does not prevent the expression of spike and wave discharges during adulthood. Seizure (2005) 0.91
18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity. J Nucl Med (2013) 0.91
Construction and evaluation of quantitative small-animal PET probabilistic atlases for [¹⁸F]FDG and [¹⁸F]FECT functional mapping of the mouse brain. PLoS One (2013) 0.90
Ictal-onset localization through connectivity analysis of intracranial EEG signals in patients with refractory epilepsy. Epilepsia (2013) 0.90
Micro-positron emission tomography imaging of rat brain metabolism during expression of contextual conditioning. J Neurosci (2012) 0.90
The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease. Clin Neurol Neurosurg (2007) 0.90